Cytogenetic analysis of CpG-oligonucleotide DSP30 plus Interleukin-2-Stimulated canine B-Cell lymphoma cells reveals the loss of one X Chromosome as the sole abnormality

Cytogenet Genome Res. 2011;135(1):79-82. doi: 10.1159/000330126. Epub 2011 Jul 28.

Abstract

Human and canine lymphoid neoplasms are characterized by non-random cytogenetic abnormalities. However, due to the low mitotic activity of the B cells, cytogenetic analyses of B-cell lymphoid proliferations are difficult to perform. In the present study we stimulated canine B-cell lymphoma cells with the immunostimulatory CpG-oligonucleotide DSP30 in combination with interleukin-2 (IL-2) and obtained an adequate number of metaphases. Cytogenetic analyses revealed the loss of one X chromosome as the sole cytogenetic aberration. Chromosome analysis of the corresponding blood showed a normal female karyotype. Monosomy X as the sole clonal chromosomal abnormality is found in human hematopoietic malignancies as well, thus the dog may serve as a promising animal model.

MeSH terms

  • Animals
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology
  • Cell Culture Techniques / methods*
  • Cells, Cultured
  • Cytogenetics / methods*
  • Dog Diseases* / genetics
  • Dog Diseases* / immunology
  • Dogs
  • Female
  • Humans
  • Interleukin-2 / pharmacology
  • Karyotyping
  • Lymph Nodes / immunology
  • Lymph Nodes / pathology*
  • Lymphocyte Activation
  • Lymphoma, B-Cell* / genetics
  • Lymphoma, B-Cell* / immunology
  • Metaphase
  • Monosomy*
  • Oligonucleotides / pharmacology
  • X Chromosome / chemistry*
  • X Chromosome / genetics

Substances

  • CpG-ODN DSP30
  • Interleukin-2
  • Oligonucleotides